A review conducted by Rosansarz informs that Angiotensin II (AT-II) and TGF-beta 1 collaborate in a signaling network to facilitate cardiac remodeling, a vital process in developing heart disease and clinical outcomes [45]. Here, TGFB1 is linked to heart disorder.